The U.S. Patent & Trademark Office’s Patent Trial and Appeal Board’s (PTAB) recently rejected a challenge by Thorne Research, Inc. against one of the key patents covering nicotinamide riboside, coming a few months after the PTAB ruled in favor of...
As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?
The ongoing inaction by the US Food and Drug Administration over CBD (cannabidiol) in foods and dietary supplements is having a negative impact on trademark laws, says an industry lawyer.
Indian-American ingredient supplier Sabinsa has announced it now has more than 300 patents granted on its ingredients and their uses. The company says the milestone is a demonstration of its commitment to the quality of its products and the scientific...
An upcoming webinar will explore the taxonomic changes to the genus Lactobacillus and the implications for brands, from labeling to consumer education.
Ingredient supplier Compound Solutions alleges that several raw material distributors and contract manufacturers have violated its exclusive patent for a popular exogenous ketone called goBHB.
Natural Alternatives International Inc. has filed a complaint against Creative Compounds Inc. in its ongoing effort to protect the intellectual propert surrounding its CarnoSyn brand of beta-alanine.
By Andrew Pratt and Justin Pierce, Venable LLP Intellectual Property
Complying with FDA regulations can be a long and expensive process. Small wonder then that some companies choose not to, and instead deal in unapproved ingredients or products that contain them. With the FDA constrained to pursue only the most extreme...
It has been a good year for curcumin and turmeric with market growth of 26%, new studies supporting its potential health benefits, and increasing consumer awareness. In this special focus on curcumin, we look back at some of the hottest developments and...
Sabinsa Corp. has filed patent infringement lawsuits against two Indian dietary supplement ingredient companies and their respective US distributors over the intellectual property connected to its Curcumin C3 Complex ingredient.
Mannatech Inc., a Texas-based supplement manufacturer, announced the granting of its 90th patent, with the granting of five new patents in 2013 relating to the company’s product portfolio.
